Accelerate your capsid and payload design with the 4^th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston)

As a recent whitepaper by the Alliance for Regenerative Medicine cites capsid engineering and disruptive delivery platforms as key emerging technologies in the CGT space, drug developers are heavily investing in finding and optimizing the safety, efficacy, and predictability of delivery platforms.

This is 2024’s only meeting covering the latest advances and innovations in vector development for gene therapies, uniting 90+ R&D and business development leaders to advance cutting-edge delivery platforms into the clinic. Data-driven talks, expert panels, and interactive group discussions led by 25+ industry experts will provide you with the ‘latest and greatest’ in both disruptive viral and non-viral vectors.

Join us to gain actionable insights in how to enable targeted gene delivery, reduce immunogenicity & toxicity, enhance downstream manufacturability, expand packaging capabilities, and secure funding and investment for your own vector platform.

Want to learn more? Check out the event guide here https://ter.li/nnkbb3